Market Intel: Precision Diagnostics And Focal Treatments Offer Personalized Approach To Prostate Cancer
The combined market for prostate cancer diagnostics and minimally invasive treatments is set to increase from $900m to $1.46bn in the next five years. But conservative treatment, or watchful waiting, is popular, limiting growth of newer, focal treatments.
You may also be interested in...
Start-Up Spotlight: Exo Hopes To Democratize Ultrasound With Handheld Device
Exo has raised $100m to support the development and commercialization of its “pMUT” portable ultrasound imaging system and software that makes ultrasound images easier to interpret.
RSNA 2019: AI, Machine Learning Continue To Dominate Developments In Radiology
Artificial intelligence (AI) and machine learning took center stage at this year’s Radiological Society of North America meeting in Chicago, and the pervasiveness of AI tech in new product launches was further emphasized at the RSNA’s expanded AI Showcase exhibit.
Exec Chat: Intuitive Surgical CEO Gary Guthart On Expansion, Innovation And Competition
With the opening of a new UK & Ireland headquarters last month, Intuitive Surgical is aiming to strengthen its grip on the the market as it faces increasing competition in the robotic surgery space. CEO Gary Guthart sat down with Medtech Insight at its new Oxfordshire, UK HQ to discuss expansion and innovation plans.